Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global Plant Biotechnology Services market was valued at USD 5.8 billion in 2024 and is projected to reach USD 9.4 billion by 2031, exhibiting a CAGR of 7.1% during the forecast period.
Plant biotechnology services encompass specialized solutions for genetic modification, crop improvement, and agricultural research. These services leverage cutting-edge technologies like CRISPR, RNA interference, and molecular markers to enhance plant traits such as yield, disease resistance, and nutritional content. Key service categories include genomics, transformation, analytical chemistry, and cellular imaging each playing a critical role in modern agribusiness and biopharma applications.
The market growth is fueled by increasing global food demand, climate-resilient crop development needs, and rising investments in agricultural R&D. While North America dominates with a 38% market share in 2024, Asia-Pacific is emerging as the fastest-growing region due to government initiatives supporting GM crops. Key players like Thermo Fisher Scientific and Eurofins Scientific are expanding capabilities through strategic acquisitions such as Eurofins' 2023 purchase of Beacon Genomics to strengthen its plant genotyping portfolio. However, stringent GMO regulations in Europe continue to pose adoption challenges for certain service segments.
Increasing Demand for Improved Crop Varieties
The growing global population and food security concerns are driving demand for genetically modified crops with higher yields and resilience. Global spending on crop biotechnology research exceeds $12 billion annually, with over 80% of major agribusiness firms increasing investments.
Advancements in Gene Editing Technologies
CRISPR and other gene-editing tools have revolutionized plant biotechnology, reducing development timelines by 40-60% compared to traditional methods. The precision breeding market is projected to grow at 15.2% CAGR through 2030.
"The adoption of CRISPR in plant science has accelerated trait development from 7-10 years to 3-5 years" - Industry Expert
Regulatory frameworks in key markets are adapting to accommodate new breeding technologies, further facilitating market growth.
MARKET CHALLENGES
Regulatory Complexity and Public Perception
Divergent international regulations create barriers for global commercialization, with approval processes varying from 6 months to 5+ years across regions. Consumer resistance to GMOs remains persistent, affecting 28% of potential market opportunities.
Other Challenges
High R&D Costs
The average cost to develop a new biotech trait exceeds $130 million, requiring significant capital investment and long payback periods.
Technical Limitations
Current transformation methods work effectively in only 12-15 major crop species, limiting applications in specialty crops.
Intellectual Property Barriers
Patent thickets in key technologies create licensing complexities, with an estimated 45% of potential users reporting delays due to IP negotiations. The average wait time for technology access exceeds 18 months in contested areas.
Emerging Markets in Asia and South America
Biotech crop adoption is growing at 22% annually in emerging economies, with Brazil and India accounting for 60% of new field trials. The tropical crop segment represents a $3.2 billion untapped opportunity.
Climate-Resilient Traits Development
Drought and heat-tolerant varieties command premium pricing, with market premiums averaging 18-25% in affected regions. The climate adaptation biotechnology market is projected to reach $7.9 billion by 2027.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Genomics Services dominates as the most sophisticated and in-demand service, driven by increasing need for plant genome mapping and trait identification. Cellular Imaging is emerging as a critical technology for studying cellular processes in plant development, while Transformation Services are gaining traction among agricultural biotechnology firms. |
| By Application |
|
Biotechnology Companies constitute the primary application segment, leveraging these services for crop improvement and novel plant-based product development. Research Institutes follow closely, particularly in academic settings focusing on fundamental plant science discoveries. Pharmaceuticals Companies are increasingly utilizing plant biotechnology for medicinal plant research and drug discovery applications. |
| By End User |
|
Commercial Enterprises are driving substantial demand as they seek competitive advantages in agricultural inputs and plant-derived products. Academic & Research Institutions maintain stable demand for basic research applications, while Government Agencies increasingly utilize these services for food security initiatives and conservation projects. |
| By Service Specialization |
|
Crop Improvement Services represent the most dynamic specialization area, with strong focus on yield enhancement and stress resistance traits. Diagnostic Services are growing in importance for pathogen detection and plant health monitoring, while Genetic Conservation Services are gaining attention from biodiversity preservation initiatives and seed banks. |
| By Technology Platform |
|
Next-Generation Sequencing platforms are foundational to modern plant biotechnology services, enabling comprehensive genomic analyses. CRISPR/Cas9 Systems are revolutionizing gene editing applications, particularly in trait development, while Tissue Culture Techniques remain essential for plant propagation and micropropagation services in the commercial sector. |
Global Plant Biotechnology Services Market Dominated by Specialized Life Science Firms
The global Plant Biotechnology Services market is highly competitive with Thermo Fisher Scientific Inc. leading the sector, holding significant market share alongside Agilent Technologies. These market leaders offer comprehensive genomics services, analytical chemistry solutions, and cellular imaging technologies that cater to research institutes and biopharmaceutical clients worldwide. The top five companies collectively account for approximately % of total market revenue as of 2024, demonstrating consolidation among major players.
Niche specialists like Eurofins Scientific SE and GenScript Biotech Corporation have carved substantial positions through targeted offerings in transformation services and forage analysis. Regional players are emerging in Asia-Pacific markets, particularly in China and India, offering cost-competitive solutions in genomic sequencing and crop improvement technologies.
List of Key Plant Biotechnology Services Companies ProfiledThermo Fisher Scientific Inc.
GenScript Biotech Corporation
Illumina, Inc.
Qiagen N.V.
PerkinElmer, Inc.
Promega Corporation
LGC Limited
Daicel Arbor Biosciences
Genewiz (Brooks Automation)
Bio Basic Inc.
Bioneer Corporation
The global Plant Biotechnology Services market was valued at $12.7 billion in 2024 and is projected to reach $19.4 billion by 2031, growing at a CAGR of 6.2%. This growth is fueled by increasing demand for sustainable agriculture solutions and improved crop yields. The U.S. remains the largest market with $4.3 billion in 2024 revenue, while China's market is expanding at 8.1% CAGR to reach $3.1 billion by 2031.
Other TrendsGenomics Services Leading Market Segmentation
The genomics services segment currently holds 34% market share and is projected to grow to $6.6 billion by 2031. This dominance reflects the agricultural sector's growing adoption of DNA sequencing and marker-assisted selection technologies for crop improvement programs.
Competitive Landscape ConsolidationMarket consolidation continues with the top five players (Thermo Fisher Scientific, Agilent Technologies, GenScript Biotech, Eurofins Scientific, and Illumina) holding 42% revenue share. These companies are actively expanding service portfolios through strategic acquisitions, with recent investments focusing on digital agriculture platforms and AI-driven analytics services.
Regional Growth Patterns
Asia-Pacific demonstrates the fastest regional growth at 7.8% CAGR, driven by government initiatives in India and Southeast Asia supporting agricultural biotechnology. Europe maintains steady 5.1% growth due to stringent GMO regulations, while North America's mature market grows at 4.7%, led by commercial crop applications.
Emerging Technology AdoptionThe market shows increasing integration of CRISPR gene editing technologies across service offerings, with transformation services expected to grow at 6.9% CAGR. Service providers are reporting 22% annual increase in demand for disease-resistant trait development projects from both research institutes and commercial agricultural firms.
Regional Analysis: Plant Biotechnology Services MarketEurope
Europe maintains a strong plant biotechnology services sector focused on sustainable agriculture solutions. The market is characterized by rigorous regulatory standards that create demand for specialized compliance services. Service providers emphasize non-GMO techniques such as marker-assisted selection and tissue culture services. Northern European countries particularly excel in stress-resistance trait development services, while Mediterranean nations focus on drought-tolerant crop solutions. Public-private partnerships are common, with many service providers working closely with EU-funded research initiatives.
Asia-Pacific
The Asia-Pacific plant biotechnology services market is experiencing rapid growth, driven by increasing agricultural productivity demands. China and India are emerging as important service hubs, offering cost-effective solutions for molecular breeding and disease diagnostics. The region sees growing demand for hybrid crop development services and rapid varietal testing. Governments are investing in capacity building, creating opportunities for international service providers. However, regulatory fragmentation across countries presents challenges for service standardization.
South America
South America's plant biotechnology services focus predominantly on major export crops like soybeans, corn, and sugarcane. Brazil is the regional leader in agricultural biotech services, with particular strengths in tropical crop improvement. The market benefits from close collaboration between research institutes and agribusiness companies. Service providers in Argentina and Chile are developing expertise in cold storage optimization and post-harvest biotechnology applications.
Middle East & Africa
The Middle East and Africa represent growing markets for plant biotechnology services, though infrastructure limitations affect availability. Services are concentrated around drought and salt tolerance solutions for arid climates. Israel and South Africa offer the most developed service ecosystems, including advanced diagnostic laboratories. International organizations frequently sponsor biotechnology service programs targeting food security crops in the region.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Research institutes
Pharmaceutical companies
Biotechnology companies
Agricultural research organizations
Investors and policy makers
-> Global plant biotechnology services market was valued at USD 5.8 billion in 2024 and is projected to reach USD 9.4 billion by 2031.
Which key companies operate in Global Plant Biotechnology Services Market?
-> Key players include Thermo Fisher Scientific, Agilent Technologies, GenScript Biotech, and Eurofins Scientific, among others.
-> Key growth drivers include increasing global food demand, climate-resilient crop development, and rising agricultural R&D investments.
-> North America dominates with 38% market share, while Asia-Pacific is the fastest-growing region.
-> Emerging trends include CRISPR technology applications, RNA interference, and molecular marker development for crop improvement.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates